Werewolf Therapeutics, Inc.
NASDAQ:HOWL
1.44 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 134.343 | 129.315 | 157.531 | 92.57 | 17.896 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 134.343 | 129.315 | 157.531 | 92.57 | 17.896 |
| Net Receivables
| 1.35 | 6.928 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.677 | 3.957 | 7.074 | 0.688 | 0.167 |
| Total Current Assets
| 138.37 | 140.2 | 161.068 | 92.914 | 18.063 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 14.846 | 17.451 | 16.325 | 3.122 | 3.408 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 1.214 | 1.208 | 0.207 | 0.208 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 21.617 | 1.38 | 0.649 | 0.155 | 0 |
| Total Non-Current Assets
| 36.463 | 20.045 | 18.182 | 3.484 | 3.616 |
| Total Assets
| 174.833 | 160.245 | 179.25 | 96.398 | 21.679 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 1.336 | 1.221 | 2.037 | 1.021 | 0.633 |
| Short Term Debt
| 8.275 | 4.168 | 2.144 | 0.677 | 0.595 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.907 | 6.532 | 0 | 0 | 0 |
| Other Current Liabilities
| 8.86 | 12.068 | 7.693 | 3.586 | 0.816 |
| Total Current Liabilities
| 19.378 | 23.989 | 11.874 | 5.284 | 2.044 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 43.648 | 25.2 | 29.178 | 1.864 | 2.542 |
| Deferred Revenue Non-Current
| 0.433 | 1.128 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -12.409 | -14.589 | 141.113 | 41.397 |
| Total Non-Current Liabilities
| 44.081 | 13.919 | 14.589 | 142.977 | 43.939 |
| Total Liabilities
| 63.459 | 37.908 | 26.463 | 148.261 | 45.983 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 179.25 | 141.082 | 34.073 |
| Common Stock
| 0.004 | 0.003 | 0.002 | 0.002 | 0.002 |
| Retained Earnings
| -344.073 | -306.705 | -252.895 | -51.865 | -24.408 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -179.25 | -141.084 | -34.073 |
| Other Total Stockholders Equity
| 455.443 | 429.039 | 405.68 | 0.002 | 68.146 |
| Total Shareholders Equity
| 111.374 | 122.337 | 152.787 | -51.863 | -24.304 |
| Total Equity
| 111.374 | 122.337 | 152.787 | -51.863 | -24.304 |
| Total Liabilities & Shareholders Equity
| 174.833 | 160.245 | 179.25 | 96.398 | 21.679 |